Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies.
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Bal, S; Malek, E; Kansagra, A; Usmani, SZ; Vij, R; Godby, KN; Cornell, RF; Kang, Y; Umyarova, E; Giri, S; Chhabra, S; Liedtke, M; Callander, NS; Hari, P; Kumar, S; Costa, LJ
Published Date
- March 2022
Published In
Volume / Issue
- 36 / 3
Start / End Page
- 877 - 880
PubMed ID
- 34802043
Electronic International Standard Serial Number (EISSN)
- 1476-5551
Digital Object Identifier (DOI)
- 10.1038/s41375-021-01471-3
Language
- eng
Conference Location
- England